GEN Exclusives

More »

GEN Poll

More »
Jan 13, 2014

Wall Street Losers

GEN recently published a list of the top 10 worst stock performers of 2013—the 10 biotech, pharma, tools/tech, and services (CROs) company stocks whose prices fell the most during the past year. Which of the firms on this list do you think could turn things around in the near future?

Which of our 10 Wall Street Losers do you think is most likely to recuperate and go back up in value?

Amarin
 
  8.6%
Amicus Therapeutics
 
  6.5%
Ariad Pharmaceuticals
 
  40.3%
Aveo Oncology
 
  13.7%
BG Medicine
 
  7.2%
GTx
 
  5.0%
Pernix Therapeutic Holdings
 
  2.9%
Prima BioMed
 
  7.2%
Vical
 
  5.8%
XTL Biopharmaceuticals
 
  2.9%

More Polls » View Results »

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?